中光防雷(300414) - 2022 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2022 was CNY 121,512,536.42, representing a 24.27% increase compared to CNY 97,777,477.77 in the same period last year[3] - Net profit attributable to shareholders decreased by 39.38% to CNY 8,037,965.45 from CNY 13,260,617.00 year-on-year[3] - The net profit after deducting non-recurring gains and losses fell by 46.57% to CNY 6,785,140.89 compared to CNY 12,697,981.70 in the previous year[3] - Basic and diluted earnings per share decreased by 39.46% to CNY 0.0247 from CNY 0.0408 year-on-year[3] - The net profit for Q1 2022 was CNY 6,719,114.92, a decrease of 38.8% from CNY 10,865,433.45 in Q1 2021[21] - The profit attributable to the parent company's shareholders was CNY 8,037,965.45, down 39.1% from CNY 13,260,617.00 in the previous year[21] Cash Flow - The net cash flow from operating activities improved significantly, reaching CNY 26,632,385.69, a 457.15% increase from a negative CNY 7,457,020.19 in the same period last year[3] - The cash inflow from operating activities for Q1 2022 was CNY 181,380,049.68, an increase of 49% compared to CNY 121,736,347.91 in Q1 2021[24] - The company reported a significant increase in cash received from operating activities, with a rise of CNY 47,643,701.77 compared to the previous year[24] - The company's cash outflow for employee payments was CNY 33,798,144.99, an increase of 25.6% from CNY 26,904,022.25 in Q1 2021[24] Assets and Liabilities - Total assets at the end of Q1 2022 were CNY 1,137,431,103.66, down 1.64% from CNY 1,156,443,396.74 at the end of the previous year[3] - The total liabilities decreased to CNY 207,344,628.07 from CNY 233,047,174.23 year-over-year, reflecting a reduction of approximately 11%[18] - The total equity attributable to the parent company was CNY 946,085,639.75, slightly up from CNY 938,076,536.14 in the previous year[18] Operating Costs and Expenses - Operating costs rose by 42.48% to CNY 90,192,742.72, primarily due to increased revenue[7] - The total operating costs for Q1 2022 were CNY 118,251,822.55, up 33.6% from CNY 88,568,022.90 in Q1 2021[20] - Research and development expenses for Q1 2022 were CNY 12,975,350.47, an increase of 10.5% from CNY 11,747,711.92 in Q1 2021[20] Shareholder Information - The total number of common shareholders at the end of the reporting period is 22,478[9] - The largest shareholder, Sichuan Zhongguang High-tech Research Institute, holds 40.88% of shares, totaling 133,276,450 shares[9] - The total number of restricted shares at the end of the period is 14,758,531, with a significant portion held by executives[12] Credit and Impairment - The company reported a significant increase in credit impairment losses of 207.67%, amounting to CNY 2,419,320.55, due to improved collection of accounts receivable[7] - The company reported a credit impairment loss of CNY 2,419,320.55, significantly higher than CNY 786,343.17 in the previous year, indicating increased credit risk[20] Inventory and Receivables - Accounts receivable decreased to ¥280,237,759.56 from ¥319,292,622.17, indicating a reduction of approximately 12.2%[15] - Inventory increased to ¥191,654,490.51 from ¥179,144,639.93, reflecting an increase of about 7%[16] Stock Options and Performance - The company plans to cancel 2,572,000 stock options due to unmet performance conditions[13] Cash and Cash Equivalents - The company's cash and cash equivalents at the end of the period amount to ¥316,524,925.97, slightly up from ¥314,341,855.40 at the beginning of the year[15] - The total cash and cash equivalents at the end of Q1 2022 stood at CNY 314,442,472.33, an increase from CNY 290,896,806.57 at the end of Q1 2021[25] Audit Status - The report for Q1 2022 was not audited, indicating that the figures presented are preliminary and subject to change[26]